Found: 3
Select item for more details and to access through your institution.
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 559, doi. 10.3390/vaccines12050559
- By:
- Publication type:
- Article
Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
- Published in:
- PLoS ONE, 2024, v. 19, n. 4, p. 1, doi. 10.1371/journal.pone.0299215
- By:
- Publication type:
- Article
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1792, doi. 10.3390/vaccines11121792
- By:
- Publication type:
- Article